These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9089004)
1. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients. Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004 [No Abstract] [Full Text] [Related]
2. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Grundy JS; Foster RT Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626 [TBL] [Abstract][Full Text] [Related]
3. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study. Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524 [TBL] [Abstract][Full Text] [Related]
5. [Alterations in hepatitic metabolism induced by prolonged-action nifedipine in Mexican population]. Palma-Aguirre JA; Campos-Lara M; Chávez-Negrete A Gac Med Mex; 2002; 138(4):381-3. PubMed ID: 12200885 [No Abstract] [Full Text] [Related]
6. Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine. Tsutamoto T; Tsutsui T; Maeda K; Hayashi M; Wada A; Ohnishi M; Fujii M; Ishii C J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S77-81. PubMed ID: 12688402 [TBL] [Abstract][Full Text] [Related]
7. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris. Croom KF; Wellington K Drugs; 2006; 66(4):497-528. PubMed ID: 16597165 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR. Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330 [TBL] [Abstract][Full Text] [Related]
9. Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS. Toal CB; Meredith PA; Elliott HL Blood Press; 2012 Jul; 21 Suppl 1(Suppl 1):3-10. PubMed ID: 22762301 [TBL] [Abstract][Full Text] [Related]
10. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946 [TBL] [Abstract][Full Text] [Related]
11. Assessment of bioavailability of experimental controlled release microcapsules of nifedipine. Mallick S; Gupta BK; Ghosal SK Acta Pol Pharm; 2000; 57(3):175-80. PubMed ID: 11143705 [TBL] [Abstract][Full Text] [Related]
12. Long term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension. Pontremoli R; Viazzi F; Ravera M; Leoncini G; Berruti V; Bezante GP; Del Sette M; Deferrari G J Nephrol; 2001; 14(1):19-26. PubMed ID: 11281339 [TBL] [Abstract][Full Text] [Related]
13. The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine. Elliott HL; Meredith PA Postgrad Med J; 1991; 67 Suppl 3():S20-3. PubMed ID: 1836870 [TBL] [Abstract][Full Text] [Related]
14. Nifedipine gastrointestinal therapeutic system--hypertension management to improve cardiovascular outcomes. Heagerty AM Int J Clin Pract; 2005 Sep; 59(9):1112-9. PubMed ID: 16115193 [TBL] [Abstract][Full Text] [Related]
15. Long-acting nifedipine in the management of the hypertensive patient. Snider ME; Nuzum DS; Veverka A Vasc Health Risk Manag; 2008; 4(6):1249-57. PubMed ID: 19337538 [TBL] [Abstract][Full Text] [Related]
16. Dihydropyridine calcium antagonists and the trough: peak ratio: focus on adverse effects. Myers MG J Hypertens Suppl; 1994 Nov; 12(8):S73-6; discussion S76-7. PubMed ID: 7707160 [TBL] [Abstract][Full Text] [Related]
17. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fernández JR Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215 [TBL] [Abstract][Full Text] [Related]
18. Once daily nifedipine: the formulation dictates the pharmacokinetic characteristics and the therapeutic responses. Toal CB; Meredith PA; Elliott HL Int J Clin Pharmacol Ther; 2012 Mar; 50(3):202-17. PubMed ID: 22373833 [TBL] [Abstract][Full Text] [Related]
19. [The pharmacokinetic and pharmacodynamic characteristics of foridon during interaction with the metabolic oxidation inhibitor dopegit]. Kukes VG; Alekhin SN; Rumiantsev AS; Gneushev ET; Gushchin AS; Germanov DV Eksp Klin Farmakol; 1993; 56(5):38-41. PubMed ID: 8312808 [TBL] [Abstract][Full Text] [Related]
20. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine? Toal CB J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]